GNH USA

Europe — EMA

Nicergolină Lph (Nicergoline)

GNH USA supplies Nicergolină Lph (Nicergoline), a cerebral vasodilator for cognitive impairment, dementia and peripheral vascular disease.

Nicergoline

Request sourcing

1
Pack/s

What is Nicergoline?

Nicergoline, the active ingredient in Nicergolină Lph, is an ergot alkaloid presented as an oral tablet for oral use. It is used to improve cerebral blood flow in patients with cognitive impairment related to cerebrovascular disease, dementia, and peripheral vascular disease.

GNH USA supplies Nicergolină Lph as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Nicergoline used for?

Nicergoline is employed as a cerebral vasodilator to address disorders involving reduced cerebral perfusion.

- Cognitive impairment associated with cerebrovascular disease: improves cerebral blood flow and may support cognitive function. - Dementia: helps maintain cerebral circulation which can aid symptom management. - Peripheral vascular disease: enhances peripheral blood flow and reduces ischemic symptoms.

What are the side effects of Nicergoline?

Nicergoline may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: sensation of light‑headedness, especially on standing. - Headache: transient cranial discomfort. - Gastrointestinal upset: abdominal pain or dyspepsia. - Hypotension: mild reduction in blood pressure.

Serious or Rare Side Effects: - Hepatic enzyme elevation: possible liver function abnormalities. - Severe hypotension: marked drop in blood pressure requiring medical attention. - Cardiac arrhythmia: irregular heart rhythm events. - Allergic reactions: rash, pruritus, or anaphylaxis in rare cases.

What precautions apply to Nicergoline?

Before initiating Nicergolină Lph, clinicians should consider several safety aspects.

- Renal or hepatic impairment: monitor liver and kidney function regularly. - Elderly patients: observe for exaggerated hypotensive responses. - Concomitant antihypertensives: risk of additive blood‑pressure lowering. - History of migraine: may exacerbate headache symptoms. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

What does Nicergoline interact with?

Nicergoline can interact with several drug classes; interactions are grouped by clinical significance.

Major Interactions (Avoid): - Other ergot derivatives: additive risk of vasospasm. - Potent CYP3A4 inhibitors (e.g., ketoconazole): increased plasma concentrations. - Anticoagulants: enhanced bleeding tendency.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may potentiate hypotensive effect. - SSRIs or SNRIs: possible increased bleeding risk. - Alcohol: may intensify dizziness and hypotension.

Frequently asked questions

What is Nicergolină Lph used for?+
Nicergolină Lph contains nicergoline, a cerebral vasodilator indicated for cognitive impairment linked to cerebrovascular disease, certain forms of dementia, and peripheral vascular disease. By increasing blood flow to the brain and peripheral tissues, it aims to support neurological function and reduce ischemic symptoms.
How does nicergoline work?+
Nicergoline antagonizes alpha‑adrenergic receptors, causing dilation of cerebral and peripheral vessels. It also promotes nitric oxide release from the endothelium and inhibits platelet aggregation, which together enhance microcirculatory blood flow and improve oxygen delivery to affected tissues.
What is the usual dose of Nicergolină Lph?+
The prescribed dose of Nicergolină Lph is determined by the treating physician based on the individual’s clinical condition, age, and response to therapy. Dosage regimens may vary, and patients should follow the prescriber’s instructions without self‑adjusting the amount.
Is nicergoline safe in pregnancy or breastfeeding?+
Safety data for nicergoline during pregnancy and lactation are limited. It should be used only if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.
How do I order Nicergolină Lph from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does nicergoline compare with other cerebral vasodilators?+
Nicergoline is an ergot‑derived vasodilator, distinct from agents such as pentoxifylline or cilostazol, which act primarily through phosphodiesterase inhibition. Compared with other ergot alkaloids, nicergoline has a lower propensity for severe vasospasm but shares similar mechanisms of alpha‑adrenergic antagonism and platelet inhibition.
What are the storage and handling requirements for Nicergolină Lph?+
Nicergolină Lph should be stored at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct sunlight. Keep the product out of reach of children and avoid exposing it to extreme temperatures.
How is Nicergolină Lph administered?+
Nicergolină Lph is taken orally, usually with a glass of water. It may be administered with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to minimize gastrointestinal discomfort.
What are the most serious risks associated with nicergoline?+
Serious adverse events, though rare, include significant hypotension, hepatic enzyme elevation, cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience symptoms like fainting, chest pain, jaundice, or widespread rash.
Who should not use nicergoline?+
Nicergoline is contraindicated in patients with known hypersensitivity to ergot alkaloids, uncontrolled hypertension, active coronary artery disease, severe hepatic impairment, and in individuals who are pregnant or breastfeeding unless clearly indicated. It should also be avoided in patients taking other ergot derivatives.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Nicergoline
Route
Oral Use
Manufacturer
Labormed Pharma S.A.
Origin
EU

Related products

Ergotop

Ergotop

Nicergoline

Kwizda Pharma Gmbh
EU
Ergotop

Ergotop

Nicergoline

Kwizda Pharma Gmbh
EU
Nicergolin

Nicergolin

Nicergoline

Farmaceutyczna Spoldzielnia Pracy Filofarm
EU
Nicergolin Neuraxpharm

Nicergolin Neuraxpharm

Nicergoline

Neuraxpharm Arzneimittel Gmbh
EU